Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients

Detalles Bibliográficos
Autores principales: Woo, Marcel S., Steins, David, Häußler, Vivien, Kohsar, Matin, Haag, Friedrich, Elias-Hamp, Birte, Heesen, Christoph, Lütgehetmann, Marc, Schulze zur Wiesch, Julian, Friese, Manuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353821/
https://www.ncbi.nlm.nih.gov/pubmed/32654064
http://dx.doi.org/10.1007/s00415-020-10046-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353821/
https://www.ncbi.nlm.nih.gov/pubmed/32654064
http://dx.doi.org/10.1007/s00415-020-10046-8

Ejemplares similares